Cell theraputics are therapies in which cellular material is injected, grafted or implanted into a patient, mostly intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy.
This report contains market size and forecasts of Cell Theraputics in Global, including the following market information:
Global Cell Theraputics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cell Theraputics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stem Cells Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cell Theraputics include Bristol-Myers Squibb Company (Celgene), Bluebird Bio, Crispr Therapeutics, Roche (Spark Therapeutics), PTC Therapeutics, Moderna Therapeutics, Quanterix, Brainstorm Cell Therapeutics Inc. and Lineage Cell Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cell Theraputics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell Theraputics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cell Theraputics Market Segment Percentages, by Type, 2021 (%)
Stem Cells
Immunocyte
Global Cell Theraputics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cell Theraputics Market Segment Percentages, by Application, 2021 (%)
Allogeneic Cell Therapy
Autologous Cell Therapy
Xenogeneic Cell Therapy
Global Cell Theraputics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cell Theraputics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell Theraputics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cell Theraputics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb Company (Celgene)
Bluebird Bio
Crispr Therapeutics
Roche (Spark Therapeutics)
PTC Therapeutics
Moderna Therapeutics
Quanterix
Brainstorm Cell Therapeutics Inc.
Lineage Cell Therapeutics
Cti Biopharma
Atara Biotherapeutics, Inc
Adaptimmune